{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:11:14Z","timestamp":1793052674315,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T00:00:00Z","timestamp":1224547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/ncpendmet0995","type":"journal-article","created":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T08:51:36Z","timestamp":1224579096000},"page":"683-694","source":"Crossref","is-referenced-by-count":88,"title":["Mechanisms related to the pathophysiology and management of central hypothyroidism"],"prefix":"10.1038","volume":"4","author":[{"given":"Masanobu","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,21]]},"reference":[{"key":"BFncpendmet0995_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(07)60673-4","volume":"369","author":"HJ Schneider","year":"2007","unstructured":"Schneider HJ et al. (2007) Hypopituitarism. Lancet 369: 1461\u20131470","journal-title":"Lancet"},{"key":"BFncpendmet0995_CR2","first-page":"754","volume-title":"Werner and Ingabar's. The Thyroid: A Fundamental and Clinical Text","author":"E Martino","year":"2005","unstructured":"Martino E et al. (2005) Central hypothyroidism. In Werner and Ingabar's. The Thyroid: A Fundamental and Clinical Text, 754\u2013768, edn 9 (Eds Braverman LE and Utiger RD) Philadelphia, PA: Lippincott Williams & Wilkins"},{"key":"BFncpendmet0995_CR3","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1210\/jc.2004-2444","volume":"90","author":"DA van Tijn","year":"2005","unstructured":"van Tijn DA et al. (2005) Neonatal detection of congenital hypothyroidism of central origin. J Clin Endocrinol Metab 90: 3350\u20133359","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","volume":"55","author":"M Regal","year":"2001","unstructured":"Regal M et al. (2001) Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55: 735\u2013740","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0995_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1022316631809","volume":"5","author":"BM Arafah","year":"2002","unstructured":"Arafah BM (2002) Medical management of hypopituitarism in patients with pituitary adenomas. Pituitary 5: 109\u2013117","journal-title":"Pituitary"},{"key":"BFncpendmet0995_CR6","first-page":"1789","volume":"85","author":"BM Arafah","year":"2000","unstructured":"Arafah BM et al. (2000) The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 85: 1789\u20131793","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1210\/jcem-62-6-1173","volume":"62","author":"BM Arafah","year":"1986","unstructured":"Arafah BM (1986) Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62: 1173\u20131179","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1507\/endocrj.42.421","volume":"42","author":"A Tominaga","year":"1995","unstructured":"Tominaga A et al. (1995) Anterior pituitary function in patients with nonfunctioning pituitary adenoma: results of longitudinal follow-up. Endocr J 42: 421\u2013427","journal-title":"Endocr J"},{"key":"BFncpendmet0995_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1210\/jcem-37-4-595","volume":"37","author":"G Faglia","year":"1973","unstructured":"Faglia G et al. (1973) Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab 37: 595\u2013601","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1055\/s-2007-1010940","volume":"20","author":"PC Eskildsen","year":"1988","unstructured":"Eskildsen PC et al. (1988) The pituitary-thyroid axis in acromegaly. Horm Metab Res 20: 755\u2013757","journal-title":"Horm Metab Res"},{"key":"BFncpendmet0995_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1023\/A:1025377816769","volume":"5","author":"L Sibal","year":"2002","unstructured":"Sibal L et al. (2002) Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary 5: 243\u2013246","journal-title":"Pituitary"},{"key":"BFncpendmet0995_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00701-004-0413-2","volume":"147","author":"A Lubina","year":"2005","unstructured":"Lubina A et al. (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien) 147: 151\u2013157","journal-title":"Acta Neurochir (Wien)"},{"key":"BFncpendmet0995_CR13","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1210\/jc.2004-0884","volume":"89","author":"D Zayour","year":"2004","unstructured":"Zayour D et al. (2004) Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function. J Clin Endocrinol Metab 89: 5649\u20135654","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1530\/eje.1.01877","volume":"152","author":"P Kendall-Taylor","year":"2005","unstructured":"Kendall-Taylor P et al. (2005) The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152: 557\u2013567","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0995_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3171\/jns.1999.90.2.0251","volume":"90","author":"J Honegger","year":"1999","unstructured":"Honegger J et al. (1999) Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 90: 251\u2013257","journal-title":"J Neurosurg"},{"key":"BFncpendmet0995_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2265.2006.02446.x","volume":"64","author":"H Nishioka","year":"2006","unstructured":"Nishioka H et al. (2006) Magnetic resonance imaging, clinical manifestations, and management of Rathke's cleft cyst. Clin Endocrinol (Oxf) 64: 184\u2013188","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0995_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3171\/jns.2005.102.2.0189","volume":"102","author":"CJ Aho","year":"2005","unstructured":"Aho CJ et al. (2005) Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 102: 189\u2013193","journal-title":"J Neurosurg"},{"key":"BFncpendmet0995_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/BF03347537","volume":"27","author":"P Cohan","year":"2004","unstructured":"Cohan P et al. (2004) Symptomatic Rathke's cleft cysts: a report of 24 cases. J Endocrinol Invest 27: 943\u2013948","journal-title":"J Endocrinol Invest"},{"key":"BFncpendmet0995_CR19","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1210\/jc.2005-0288","volume":"90","author":"L De Marinis","year":"2005","unstructured":"De Marinis L et al. (2005) Primary empty sella. J Clin Endocrinol Metab 90: 5471\u20135477","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/BF03343996","volume":"25","author":"S Cannav\u00f2","year":"2002","unstructured":"Cannav\u00f2 S et al. (2002) Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella. J Endocrinol Invest 25: 236\u2013239","journal-title":"J Endocrinol Invest"},{"key":"BFncpendmet0995_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1530\/eje.1.01881","volume":"152","author":"F Kelestimur","year":"2005","unstructured":"Kelestimur F et al. (2005) Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS\u2014Pfizer International Metabolic Database. Eur J Endocrinol 152: 581\u2013587","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0995_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1507\/endocrj.50.415","volume":"50","author":"H Onose","year":"2003","unstructured":"Onose H et al. (2003) A case of Sheehan's syndrome with panhypopituitarism due to the impairment of both the hypothalamus and the pituitary. Endocrine J 50: 415\u2013419","journal-title":"Endocrine J"},{"key":"BFncpendmet0995_CR23","first-page":"1694","volume":"86","author":"JH Oliveira","year":"2001","unstructured":"Oliveira JH et al. (2001) Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab 86: 1694\u20131699","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.ijrobp.2007.01.029","volume":"68","author":"N Bhandare","year":"2007","unstructured":"Bhandare N et al. (2007) Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 68: 1131\u20131139","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncpendmet0995_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/cncr.22860","volume":"110","author":"DS Kong","year":"2007","unstructured":"Kong DS et al. (2007) The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 110: 854\u2013860","journal-title":"Cancer"},{"key":"BFncpendmet0995_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1001\/jama.298.12.1429","volume":"298","author":"HJ Schneider","year":"2007","unstructured":"Schneider HJ et al. (2007) Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 298: 1429\u20131438","journal-title":"JAMA"},{"key":"BFncpendmet0995_CR27","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1210\/jcem.85.4.6506","volume":"85","author":"S Benvenga","year":"2000","unstructured":"Benvenga S et al. (2000) Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 85: 1353\u20131361","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/ncpendmet0460","volume":"3","author":"G Aimaretti","year":"2007","unstructured":"Aimaretti G and Ghigo E (2007) Should every patient with traumatic brain injury be referred to an endocrinologist. Nat Clin Pract Endocrinol Metab 3: 318\u2013319","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"BFncpendmet0995_CR29","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1210\/en.2005-0706","volume":"147","author":"V Sharma","year":"2006","unstructured":"Sharma V et al. (2006) Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis. Endocrinology 147: 1438\u20131451","journal-title":"Endocrinology"},{"key":"BFncpendmet0995_CR30","first-page":"581","volume":"137","author":"M Duvic","year":"2001","unstructured":"Duvic M et al. (2001) Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Arch Dermatol 137: 581\u2013593","journal-title":"Arch Dermatol"},{"key":"BFncpendmet0995_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1210\/jc.2006-0696","volume":"92","author":"WM Golden","year":"2007","unstructured":"Golden WM et al. (2007) Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects. J Clin Endocrinol Metab 92: 124\u2013130","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR32","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJM199904083401404","volume":"340","author":"SI Sherman","year":"1999","unstructured":"Sherman SI et al. (1999) Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 340: 1075\u20131079","journal-title":"N Engl J Med"},{"key":"BFncpendmet0995_CR33","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1210\/jc.2006-2822","volume":"92","author":"JW Smit","year":"2007","unstructured":"Smit JW et al. (2007) Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones. J Clin Endocrinol Metab 92: 2496\u20132499","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR34","doi-asserted-by":"publisher","first-page":"E326","DOI":"10.1152\/ajpendo.00313.2001","volume":"283","author":"PE Macchia","year":"2002","unstructured":"Macchia PE et al. (2002) RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor. Am J Physiol Endocrinol Metab 283: E326\u2013E331","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFncpendmet0995_CR35","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1210\/jcem.87.5.8479","volume":"87","author":"S Porretti","year":"2002","unstructured":"Porretti S et al. (2002) Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T4 therapy become mandatory. J Clin Endocrinol Metab 87: 2042\u20132045","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2006.02688.x","volume":"66","author":"A Agha","year":"2007","unstructured":"Agha A et al. (2007) Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) 66: 72\u201377","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0995_CR37","first-page":"3493","volume":"83","author":"DT Wyatt","year":"1998","unstructured":"Wyatt DT et al. (1998) Changes in thyroid hormone levels during growth hormone therapy in initially euthyroid patients: lack of need for thyroxine supplementation. J Clin Endocrinol Metab 83: 3493\u20133497","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR38","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1210\/jc.2007-0941","volume":"92","author":"MR Martins","year":"2007","unstructured":"Martins MR et al. (2007) Growth hormone replacement improves thyroxine biological effects: implications for management of central hypothyroidism. J Clin Endocrinol Metab 92: 4144\u20134153","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2004-0011","volume":"26","author":"P Caturegli","year":"2005","unstructured":"Caturegli P et al. (2005) Autoimmune hypophysitis. Endocr Rev 26: 599\u2013614","journal-title":"Endocr Rev"},{"key":"BFncpendmet0995_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1507\/endocrj.K06-055","volume":"53","author":"K Hashimoto","year":"2006","unstructured":"Hashimoto K et al. (2006) Longitudinal study of patients with idiopathic isolated TSH deficiency: possible progression of pituitary dysfunction in lymphocytic adenohypophysitis. Endocr J 53: 593\u2013601","journal-title":"Endocr J"},{"key":"BFncpendmet0995_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0022-3476(96)70405-5","volume":"128","author":"KA Skuza","year":"1996","unstructured":"Skuza KA et al. (1996) Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease. J Pediatr 128: 264\u2013268","journal-title":"J Pediatr"},{"key":"BFncpendmet0995_CR42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1210\/jc.2006-1538","volume":"92","author":"J Kempers M","year":"2007","unstructured":"Kempers M J et al. (2007) Neonatal screening for congenital hypothyroidism in the Netherlands: cognitive and motor outcome at 10 years of age. J Clin Endocrinol Metab 92: 919\u2013924","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR43","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1542\/peds.2004-2128","volume":"115","author":"R Higuchi","year":"2005","unstructured":"Higuchi R et al. (2005) Central hypothyroidism in infants who were born to mothers with thyrotoxicosis before 32 weeks' gestation: 3 cases. Pediatrics 115: e623\u2013e625","journal-title":"Pediatrics"},{"key":"BFncpendmet0995_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1203\/00006450-199708000-00014","volume":"42","author":"N Matsuura","year":"1997","unstructured":"Matsuura N et al. (1997) The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Pediatr Res 42: 214\u2013218","journal-title":"Pediatr Res"},{"key":"BFncpendmet0995_CR45","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1210\/jc.2006-2042","volume":"92","author":"MJ Kempers","year":"2007","unstructured":"Kempers MJ et al. (2007) Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease. J Clin Endocrinol Metab 92: 2984\u20132991","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1507\/endocrj.KR-107","volume":"54","author":"K Miyai","year":"2007","unstructured":"Miyai K (2007) Congenital thyrotropin deficiency\u2014from discovery to molecular biology, postgenome and preventive medicine. Endocr J 54: 191\u2013203","journal-title":"Endocr J"},{"key":"BFncpendmet0995_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-2006-924232","volume":"114","author":"CJ Partsch","year":"2006","unstructured":"Partsch CJ et al. (2006) Initially elevated TSH and congenital central hypothyroidism due to a homozygous mutation of the TSH beta subunit gene: case report and review of the literature. Exp Clin Endocrinol Diabetes 114: 227\u2013234","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BFncpendmet0995_CR48","first-page":"1561","volume":"82","author":"R Collu","year":"1997","unstructured":"Collu R et al. (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82: 1561\u20131565","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR49","first-page":"98","volume":"49","author":"MR Brown","year":"1998","unstructured":"Brown MR et al. (1998) Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Horm Res 49: 98\u2013102","journal-title":"Horm Res"},{"key":"BFncpendmet0995_CR50","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1210\/jc.2005-0570","volume":"90","author":"JP Turton","year":"2005","unstructured":"Turton JP et al. (2005) Novel mutations within POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 90: 4762\u20134770","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1053\/beem.2002.0218","volume":"16","author":"S Mody","year":"2002","unstructured":"Mody S et al. (2002) The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab 16: 421\u2013431","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000110610","volume":"68","author":"D Kelberman","year":"2007","unstructured":"Kelberman D et al. (2007) Hypopituitarism oddities: congenital causes. Hormone Res 68: 138\u2013144","journal-title":"Hormone Res"},{"key":"BFncpendmet0995_CR53","doi-asserted-by":"publisher","first-page":"10862","DOI":"10.1073\/pnas.94.20.10862","volume":"94","author":"M Yamada","year":"1997","unstructured":"Yamada M et al. (1997) Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci USA 94: 10862\u201310867","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpendmet0995_CR54","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1210\/me.2004-0017","volume":"18","author":"R Rabeler","year":"2004","unstructured":"Rabeler R et al. (2004) Generation of thyrotropin-releasing hormone receptor 1-deficient mice as an animal model of central hypothyroidism. Mol Endocrinol 18: 1450\u20131460","journal-title":"Mol Endocrinol"},{"key":"BFncpendmet0995_CR55","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1210\/me.2007-0048","volume":"21","author":"H Zeng","year":"2007","unstructured":"Zeng H et al. (2007) Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol Endocrinol 21: 2795\u20132804","journal-title":"Mol Endocrinol"},{"key":"BFncpendmet0995_CR56","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1172\/JCI26240","volume":"116","author":"A Hernandez","year":"2006","unstructured":"Hernandez A et al. (2006) Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 116: 476\u2013484","journal-title":"J Clin Invest"},{"key":"BFncpendmet0995_CR57","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1210\/en.2007-0652","volume":"148","author":"A Hernandez","year":"2007","unstructured":"Hernandez A et al. (2007) Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis. Endocrinology 148: 5680\u20135687","journal-title":"Endocrinology"},{"key":"BFncpendmet0995_CR58","first-page":"3631","volume":"85","author":"L Persani","year":"2000","unstructured":"Persani L et al. (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85: 3631\u20133635","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR59","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJM198504253121703","volume":"312","author":"P Beck-Peccoz","year":"1985","unstructured":"Beck-Peccoz P et al. (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism: effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312: 1085\u20131090","journal-title":"N Engl J Med"},{"key":"BFncpendmet0995_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/thy.2006.0311","volume":"17","author":"H Atmaca","year":"2007","unstructured":"Atmaca H et al. (2007) Do we still need the TRH stimulation test? Thyroid 17: 529\u2013533","journal-title":"Thyroid"},{"key":"BFncpendmet0995_CR61","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1210\/jc.2006-2656","volume":"93","author":"DA van Tijn","year":"2008","unstructured":"van Tijn DA et al. (2008) Role of the thyrotropin-releasing hormone stimulation test in diagnosis of congenital central hypothyroidism in infants. J Clin Endocrinol Metab 93: 410\u2013419","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR62","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1210\/jc.2003-030943","volume":"88","author":"A Mehta","year":"2003","unstructured":"Mehta A et al. (2003) Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 88: 5696\u20135703","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR63","first-page":"1124","volume":"80","author":"M Horimoto","year":"1995","unstructured":"Horimoto M et al. (1995) Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3,5,3'-triiodothyronine response to TSH and in vitro bioactivity of TSH. J Clin Endocrinol Metab 80: 1124\u20131128","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/s-0029-1212080","volume":"107","author":"H M\u00f6nig","year":"1999","unstructured":"M\u00f6nig H et al. (1999) Blunted nocturnal TSH surge does not indicate central hypothyroidism in patients after pituitary surgery. Exp Clin Endocrinol Diabetes 107: 89\u201392","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BFncpendmet0995_CR65","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1210\/jc.2005-1593","volume":"90","author":"KH Darzy","year":"2005","unstructured":"Darzy KH and Shalet SM (2005) Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J Clin Endocrinol Metab 90: 6490\u20136497","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR66","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1210\/jc.2007-0297","volume":"92","author":"M Slawik","year":"2007","unstructured":"Slawik M et al. (2007) Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. J Clin Endocrinol Metab 92: 4115\u20134122","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje.0.1500001","volume":"150","author":"O Alexopoulou","year":"2004","unstructured":"Alexopoulou O et al. (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150: 1\u20138","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0995_CR68","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1056\/NEJM200106073442302","volume":"344","author":"BM Arafah","year":"2001","unstructured":"Arafah BM (2001) Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344: 1743\u20131749","journal-title":"N Engl J Med"},{"key":"BFncpendmet0995_CR69","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1210\/jc.2006-0448","volume":"91","author":"S Grozinsky-Glasberg","year":"2006","unstructured":"Grozinsky-Glasberg S et al. (2006) Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 91: 2592\u20132599","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR70","first-page":"924","volume":"84","author":"E Ferretti","year":"1999","unstructured":"Ferretti E et al. (1999) Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84: 924\u2013929","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0995_CR71","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","volume":"84","author":"SM Webb","year":"1999","unstructured":"Webb SM et al. (1999) Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 84: 3696\u20133700","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0995","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T18:16:34Z","timestamp":1709316994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,21]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFncpendmet0995"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0995","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,21]]}}}